Table 2.

Details and timing of data collection

Measures		Month
		0	3	6	9	12
Clinical	Rx, comorbidity	x				x
	Behavioural change recommendations made; Rx changes prescribed		x	x	x	x
Biometric	Weight, height	x				x
Glycaemia	HbA1c	x		x		x
Other path	Lipids, creatinine, spot urine albumin–creatinine ratio	x				x
r-CGM	AGP	x	x*	x*	x*	x
Psycho-social	Diabetes distress: Problem Areas in Diabetes scale41 Satisfaction with and user experience of glucose monitoring: Glucose Monitoring Experience Questionnaire49 General Emotional Well-being: WHO (five) Well-being Index50 Hypoglycaemia frequency and severity: selected items from the Hypoglycaemia Awareness Questionnaire51 Diabetes-specific quality of life: DAWN Impact of Diabetes Profile 52 Health status: EuroQoL 5 Dimensions 53 Summary of Diabetes Self-care Activities 54 Perceived involvement in Self-Care scale55	x				x

*Data collected for intervention arm only.

AGP, ambulatory glucose profile; r-CGM, retrospective continuous glucose monitoring.